Schellenberg Wittmer advised BASF — a chemical company whose core business includes chemicals, materials, industrial solutions and nutrition & care — on the sale of its optical brightening agent business to Catexel. The transaction encompasses the international
Bär & Karrer advised Bitwise, a U.S.-based crypto investment firm with more than USD 15 billion in assets under management, on its acquisition of Chorus One, an infrastructure provider for staking services on
Swiss healthcare company Novartis, acting through one of its wholly-owned indirect subsidiaries, completed the acquisition of RNA therapeutics specialist Avidity Biosciences, for a total value of approximately USD 12 bn. In connection with the deal, Homburger
Bratschi expands its in tenancy and real estate law lineup in Lausanne with the appointment of partner Ingrid Cueva Molnar (pictured), effective since 1 March 2026. Moving from HCML Avocats, the one of Cueva Molnar is a
KPMG has officially appointed Hélène Weidmann (pictured) as a partner in its tax & legal department, effective 1 March 2026. Weidmann joins from MLL Legal and will lead KPMG Law Western Switzerland, in addition to
Schellenberg Wittmer expands its partnership lineup with the addition of two new partners and one counsel: partner Sara Rousselle-Ruffieux, joining in the firm’s Geneva office as of March 1st 2026, Roland Ryser, appointed partner in
LEXR Law officialised the appointment of Stephan D. Meyer (pictured) as a partner. Effective March 1st 2026, Meyer will lead LEXR’s blockchain and fintech team in Zurich. Stephan D. Meyer’s expertise spans the areas
Walder Wyss advised Swiss TEPU Holding, which consists of the companies Pfanner & Frei and re.com Elektroanlagen, on the sale of majority stakes to the TSG Group, a European provider of technical services for
Kellerhals Carrard advised Kaspar&, a specialist in white-label and B2B solutions for financial institutions, on the sale of all shares in the company to Liberty Vorsorge, a Swiss independent provider of pension and
Welcome to Signed, Sealed, Weekend — our weekly inside track into the Swiss legal market. Check out the news of the week: · VISCHER advised FimmCyte, a Swiss biotech developing targeted immunotherapies for chronic fibro-inflammatory diseases, in
